热门话题-Dexcom股价因计划改组董事会而上涨最新动态
5月15日 - ** Dexcom（DXCM.O）股价上涨8.4%，报62.69美元
** 这家医疗设备制造商表示，已同意与其最大投资者之一埃利奥特投资管理公司（Elliott Investment Management）合作 (link)，物色两名新的独立董事
** 首席执行官杰克·利奇（Jake Leach）在投资者电话会议上表示，DXCM正致力于更新董事会，并寻求引入具备医疗科技和运营专长的独立董事
** 若此次任命得以落实，自2023年初以来，该公司董事会将累计任命六名新独立董事——DXCM
** 威廉·布莱尔（William Blair）称DXCM的投资者简报“积极”，并指出其“长期营收增长前景稳固”、回购计划增加，且对产品管线提供了“更多细节”
** 该券商称，DXCM与艾略特管理公司（Elliott Management）合作以强化董事会是“又一积极信号”
** 计入当日交易，DXCM今年以来累计下跌5.6%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
At the request of the copyright holder, you need to log in to view this content
LOGIN / SIGN UPDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.